Pruebas Indican Que Pastilla De Covid Puede Tener Éxito
GLENDALE, CA - JANUARY 04: Xenadrine EFX capsules are photographed on January 4, 2007 in Glendale, California. The marketers of four weight loss products, Xenadrine EFX, One-A-Day Weight Smart, CortiSlim and TrimSpa, were fined $25 million by the Federal Trade Commission on January 4 for making false advertising claims. The marketers of Xenadrine EFX, made by Nutraquest, Inc., were levied the largest fine and will pay between $8 million and $12.8 million. The investigated claims included rapid weight loss, reduction in the risk of osteoporosis, Alzheimer's, and cancer. (Photo Illustration by David McNew/Getty Images)
Una nueva medicina esta en desarrollo y las pruebas preliminares demuestran mucha promesa contra el Covid-19 al usar el medicamento como un tratamiento.
Sign me up for the 106.9 Playa email newsletter!
Obtendrá acceso a concursos en línea exclusivos, preventas de boletos, invitaciones a eventos VIP, ofertas increíbles y otras cosas divertidas – todo entregado directamente a su in-box!
By clicking "Subscribe" I agree to the website's terms of Service and Privacy Policy. I understand I can unsubscribe at any time.